SREBF1 and fatty liver disease: Hydroxytyrosol can also correct metabolic deficiencies in diet-induced obesity in mice by correcting the aberrant expression of genes involved in hepatic lipogenesis (SREBP1, ACC, FAS, and Stearoyl-CoA desaturase-1), decreasing hepatic steatosis from induced obesity [22].